2025 Japan Blood Testing Market Revenue Opportunities Report
Description
The 2025 Japan Blood Testing Market Revenue Opportunities Report features 1) market size data for the region or country, 2) annual market growth rates, 3) the market's impact on related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing, 4) Total Addressable Market (TOM) for the four largest market players, 5) Serviceable Addressable Market (SAM), and 6) Serviceable Obtainable Market (SOM)(Wharry Sharpe Research)
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Blood Testing Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the blood testing market in Japan include H.U. Group Holdings (SRL and Fujirebio), C₂N Diagnostics via Mediford Corporation, Terumo Corporation, and IQVIA Laboratories. H.U. Group, with its SRL laboratories and Fujirebio diagnostics arm, is Japan's largest laboratory testing center with advanced automated and AI-enhanced testing facilities, focusing on general and specialized tests like genetic and oncology testing. C₂N Diagnostics expanded into Japan through a partnership with Mediford Corporation to offer high-sensitivity blood tests for neurological diseases, including Alzheimer's biomarkers, leveraging precision mass spectrometry technologies.
Terumo Corporation, headquartered in Tokyo, is a major global player providing innovative medical and diagnostic solutions, including cardiovascular-related diagnostics, benefitting from Japan's aging population and healthcare needs. IQVIA Laboratories operates in Japan offering comprehensive clinical trial laboratory services, recognized globally for high-quality CAP and ISO15189 certifications, supporting clinical research and diagnostic testing. These companies leverage innovative technologies and cater to Japan's advanced healthcare system focused on improving disease diagnosis, treatment monitoring, and research.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Blood Testing Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the blood testing market in Japan include H.U. Group Holdings (SRL and Fujirebio), C₂N Diagnostics via Mediford Corporation, Terumo Corporation, and IQVIA Laboratories. H.U. Group, with its SRL laboratories and Fujirebio diagnostics arm, is Japan's largest laboratory testing center with advanced automated and AI-enhanced testing facilities, focusing on general and specialized tests like genetic and oncology testing. C₂N Diagnostics expanded into Japan through a partnership with Mediford Corporation to offer high-sensitivity blood tests for neurological diseases, including Alzheimer's biomarkers, leveraging precision mass spectrometry technologies.
Terumo Corporation, headquartered in Tokyo, is a major global player providing innovative medical and diagnostic solutions, including cardiovascular-related diagnostics, benefitting from Japan's aging population and healthcare needs. IQVIA Laboratories operates in Japan offering comprehensive clinical trial laboratory services, recognized globally for high-quality CAP and ISO15189 certifications, supporting clinical research and diagnostic testing. These companies leverage innovative technologies and cater to Japan's advanced healthcare system focused on improving disease diagnosis, treatment monitoring, and research.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
Table of Contents
51 Pages
- A. Definitions
- A1. Market Definition
- A2. Market Segmentation
- A3. Industry Opportunities-Industry1
- A4. Industry Opportunities-Industry2
- A5. Industry Opportunities-Industry3
- B. Total Addressable Market (TAM)
- B1. TAM-Player 1/4
- B2. TAM-Player 2/4
- B3. TAM-Player 3/4
- B4. TAM-Player 4/4
- C. Serviceable Addressable Market (SAM)
- C1. SAM-Player 1/4
- C2. SAM-Player 2/4
- C3. SAM-Player 3/4
- C4. SAM-Player 4/4
- D. Serviceable Obtainable Market (SOM)
- D1. SOM-Player 1/4
- D2. SOM-Player 2/4
- D3. SOM-Player 3/4
- D4. SOM-Player 4/4
- E. Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
